Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
2009
Matrix Protein CCN1 Is Critical for Prostate Carcinoma Cell Proliferation and TRAIL-Induced Apoptosis
2009 Standout
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
2017 Science
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?
2004
Virtual reality cue exposure for the relapse prevention of tobacco consumption: a study protocol for a randomized controlled trial
2016
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres
2010 Standout
Keratin 8/18 breakdown and reorganization during apoptosis
2004
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006 Standout
Prognostic Factors in Non-small Cell Lung Cancer
2002
Ki67 protein: the immaculate deception?
2002
Weekly Dose-Dense Cisplatin-Epirubicin-Paclitaxel Administration with Granulocyte Colony-Stimulating Factor Support Does Not Substantially Improve Prognosis in Extensive Disease Small-Cell Lung Cancer
2005
Symptoms tell it all: A systematic review of the value of symptom assessment to predict survival in advanced cancer patients
2012
A view on drug resistance in cancer
2019 StandoutNature
Cell death by mitotic catastrophe: a molecular definition
2004
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Almost all articles on cancer prognostic markers report statistically significant results
2007
Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project
2008
The 2004 World Health Organization classification of lung tumors
2005 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
2003
A Systematic Review of Quality of Life Associated with Standard Chemotherapy Regimens for Advanced Non-small Cell Lung Cancer
2007
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
2006 Standout
Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials
2007
Selective Reporting Biases in Cancer Prognostic Factor Studies
2005
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma
2003
Induction chemotherapy and radiotherapy in locally advanced non–small cell lung cancer
2004
Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials
2006
The human keratins: biology and pathology
2008 Standout
Nasopharyngeal carcinoma
2019 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21‐1) in the differentiation of malignant and benign pleural effusions
1999
Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data
2010 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Neutrophil metabolism in the cancer context
2021
Large cell neuroendocrine carcinoma of the lung: A clinicopathologic study of eighty-seven cases
2002
Fertility and infertility: Definition and epidemiology
2018 Standout
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
2001
Determinants and clinical implications of chromosomal instability in cancer
2018
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Clinical utility of cytokeratins as tumor markers
2004
Profiling cytogenetic diversity with entropy-based karyotypic analysis
2005
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study
2007
Virtual reality in the assessment, understanding, and treatment of mental health disorders
2017 Standout
Emerging ethnic differences in lung cancer therapy
2008
A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index
2005
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Small-cell lung cancer
2005
Cancer as an evolutionary and ecological process
2006 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Randomized Multicenter Phase II Study of Larotaxel (XRP9881) in Combination with Cisplatin or Gemcitabine as First-Line Chemotherapy in Nonirradiable Stage IIIB or Stage IV Non-small Cell Lung Cancer
2008
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Angiogenesis inhibitors under study for the treatment of lung cancer
2003
The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer
2006
Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer
2001
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
Small-cell lung cancer
2011
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Impact of Third-Generation Drugs on the Activity of First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analytical Approach
2009
Chemotherapy for advanced non-small cell lung cancer in the elderly population
2015
Mendelian randomisation approaches to the study of prenatal exposures: A systematic review
2020
Head and Neck Cancer
2020 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
2014 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
2002
Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization
2021 Standout
Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study
2004
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease
2003 Standout
Pleural Effusion
2002 Standout
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
2015 Standout
Exercise interventions for smoking cessation
2014
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Xavier Quantin being referenced
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO* analysis of prognostic factors
2001
Physical Activity as a Protective Factor in Relapse Following Smoking Cessation in Participants with a Depressive Disorder
2012
Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data
2001
Etoposide Plus Cisplatin With or Without the Combination of 4'-Epidoxorubicin Plus Cyclophosphamide in Treatment of Extensive Small-Cell Lung Cancer: a French Federation of Cancer Institutes Multicenter Phase III Randomized Study
2001
Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers
1996
Predictive Factors of Tumor Response and Prognostic Factors of Survival during Lung Cancer Chemotherapy
1998
Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS.
1996
Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin
2005
Apport des thérapies cognitivo-comportementales dans le sevrage tabagique
2007
Concomitant brain radiotherapy and vinorelbine–ifosfamide–cisplatin chemotherapy in brain metastases of non-small cell lung cancer
1999
Effects of cigarette smoking on reproduction
2010
Smoking Cessation, Depression, and Exercise: Empirical Evidence, Clinical Needs, and Mechanisms
2013
Neoadjuvant Etoposide, Ifosfamide, and Cisplatin Followed by Concomitant Thoracic Radiotherapy and Continuous Cisplatin Infusion in Stage IIIb Non-small Cell Lung Cancer
1999
Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients
2001
Neutrophils in the era of immune checkpoint blockade
2021
Immunohistochemical detection of p53 protein and prognosis of surgically resected non-small-cell lung cancer.
1997